Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-12-13 12:43:18
Reporting Period:
Filing Date:
Accepted Time:
2013-12-13 12:43:18
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1561743 Kindred Biosciences Inc. KIN Pharmaceutical Preparations (2834) 461160142
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593868 Kevin Schultz C/o Kindred Biosciences, Inc.
1499 Bayshore Highway, Suite 226
Burlingame CA 94010
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-12 4,000 $7.00 4,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. These shares were purchased through a directed share program in connection with the Issuer's initial public offering.